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Abstract
Introduction: Maturity-onset diabetes mellitus affecting the elderly population is marked by insulin 
resistance and decreased insulin production. The relationship between periodontitis and diabetes 
is bidirectional. Type 2 diabetic patients are more prone to chronic periodontitis (CP) and severe 
periodontitis affects the glycemic control in such patients. Recently, dental diode laser has become an 
effective tool in controlling CP. To date, very few studies have been conducted to check the efficacy 
of diode laser in control of periodontal destruction in type 2 diabetes mellitus (DM2) patients. Hence, 
the need of the study was to evaluate whether diode laser helps improvement of periodontal outcome 
and reduction in anaerobic bacteria in elderly diabetic patients with CP. 
Methods: Forty DM2 patients with CP were randomized into group A (control): scaling and root planing 
(SRP) only and group B (test): SRP followed by soft tissue dental diode laser (808 nm) application. Four 
patients (2 in each group) were lost during follow up. Clinical parameters, plaque samples and glycated 
hemoglobin levels were evaluated at both baseline and 90 days post-treatment.
Results: Improvement in clinical, microbiological and glycemic parameters were noted in the group 
that received SRP as well as SRP + LANAP (laser-assisted new attachment procedure). The reductions 
in clinical parameters were statistically significant after 3 months (P < 0.001). The microbial analysis 
of plaque samples for Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas gingivalis 
(Pg) decreased significantly after 3 months in group B than in group A. Glycated hemoglobin level 
(HbA1c) decreased significantly after 90 days in both the groups (P < 0.001) with more reduction in 
the SRP+LANAP group (6.49%) in comparison to SRP alone (16.25% vs. 9.76%). However, on the 
intergroup comparison, the difference in HbA1c reduction was nonsignificant.
Conclusion: Laser as an adjunct to SRP is an effective procedure for improving clinical and 
microbiological parameters in maturity onset diabetes mellitus patients with CP. Also, there was 
a better improvement in glycemic control in the test group compared to control group after 3 
months. Hence, medically compromised patients like DM2 with CP with delayed wound healing 
can effectively be treated by laser as an adjunct to nonsurgical periodontal therapy for better results.
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Introduction
Chronic periodontitis (CP) is a multifactorial disease 
caused by various periodontopathogenic bacteria that 
results in the destruction of the tooth-supporting tissues 
i.e. periodontal tissue.1 Diabetes mellitus is a chronic 
metabolic disorder of the pancreas that results in marked 
hyperglycemia due to insulin resistance and decreased 
production of insulin by the pancreas.2,3 Non-insulin 
dependent diabetes mellitus (NIDDM) also known as 
type 2 diabetes mellitus (DM2) is more common in the 
elderly population. Periodontitis is considered a sixth 
complication in diabetic patients. The relationship 
between Periodontitis and NIDDM is bidirectional. 
NIDDM predisposes an individual to the risk of 
developing CP, and severe periodontitis affects glycemic 
control in diabetic patients.4 Few meta-analyses studies 
have confirmed that HbA1c reduction of around 0.4% can 
be anticipated following effective periodontal therapy.5
The primary etiological factor for the existence of 
periodontitis is pathogenic microorganisms within the 
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subgingival biofilm. Specific periodontopathogenic 
bacterial species and their virulence factors have been 
recognized as etiological agents and they affect the 
rate of progression of the disease. Hence, they act as 
indicators for progression of periodontal breakdown.6 
Today about a dozen oral microorganisms are classified 
as periodontal pathogens. Foremost among these are 
gram-negative organisms including Aggregatibacter 
actinomycetemcomitans (Aa) and Porphyromonas 
gingivalis (Pg).7
The elimination of subgingival microorganism and 
regeneration of lost tissue is considered as the most 
important goal of periodontal therapy. Successful 
periodontal therapy is determined by control of 
destructive periodontal pathogens along with a shift in 
the microbial flora towards one that is typically present in 
health.8-10 This elimination of the pathogenic subgingival 
microbiota can be achieved by nonsurgical periodontal 
therapy which is considered as the gold standard for a 
plaque as well as microbial elimination.10-12 However, 
previous studies have shown that nonsurgical periodontal 
therapy alone may fail to completely eliminate the 
pathogenic subgingival microbiota because of limited 
access to the instruments, as a result, this may lead to 
persistent periodontopathogens.10,13-15 These limitations of 
mechanical therapy have led to a shift to other adjunctive 
measures such as the use of antimicrobial therapy.
The spread of localized inflammation which is closely 
associated with the destruction of the supporting 
periodontal tissue is promoted by the microbial 
colonization, especially the gram-negative anaerobic 
bacteria in deep inaccessible areas such as furcation areas 
and root concavities. This justifies the need for the bacterial 
elimination from periodontal pockets.16 Mechanical 
methods such as scaling and root planing (SRP) are 
not sufficient for the complete bacterial elimination.17,18 
Systemic antibiotics have been employed in cases which 
are nonresponsive to conventional periodontal treatments 
in spite of the known systemic side effects of antibiotics 
and the development of antibiotic resistance.1,19 Dental 
diode laser system has become an effective tool when 
used along with conventional periodontal therapy 
resulting in significant bacterial reduction which makes 
the adjunctive use of antibiotics almost unnecessary.20
Lasers have been used in periodontal therapy since long 
for subgingival curettage, gingivectomy, frenectomy, 
removal of granulation tissue, during flap surgery, osseous 
recontouring, implant maintenance and management of 
peri-implantitis.
The antimicrobial efficacy of diode laser has been proven 
in a number of studies.7 Due to its exceptional ease of use 
and affordability as well as action on various pigmented 
periodontal pathogens the diode laser has become an 
integral tool in the dental armamentarium. 21 It is well 
absorbed by various chromophores present in diseased 
periodontal tissues such as melanin and hemoglobin.22 
These evidence in the dental literature states diode laser 
is a useful adjunct to nonsurgical periodontal therapy in 
producing improved results.23
Although several studies have shown the efficacy of soft 
tissue diode laser therapy over SRP alone in the treatment 
of CP, very few studies were done in NIDDM patients 
who are frequently affected by CP due to bidirectional 
relationship and to assess whether laser-assisted new 
attachment procedure (LANAP) has additional systemic 
beneficial effect on glycemic control, improvement in 
overall clinical outcome and the reduction in periodontal 
microbiology.
Methods
A total of 40 DM2 patients with CP were selected from 
the Department of Periodontology, JSS Dental College, 




• Patients between 30-60 years of age with confirmed 
diagnosis of DM2 and chronic generalized 
periodontitis with ≥20 teeth remaining.
• The periodontal pocket depth of 4-7 mm with clinical 
attachment level (CAL) of 2 mm or greater and each 
quadrant having at least 3 teeth.
• Consenting patients who were cooperative and able 
to come for regular follow up.
Exclusion Criteria
• Pregnant/lactating women.
• Patients who were on antibiotic therapy in the 
previous six months.
• Patients who had undertaken any periodontal 




By purposive sampling, 40 patients were selected who 
fulfilled the inclusion criteria. Four patients (2 in test and 
2 in control) were lost during follow-up. After baseline 
examination, 36 patients were assigned randomly to test 
and control group of 18 patients each (Figure 1).
Study Design
This was a parallel design, randomized, single-blind, and 
controlled clinical trial of 3 months duration. The study 
was conducted to compare and evaluate Diode Laser 
therapy as an adjunct to SRP in NIDDM patients with CP.
• Group A (Control group): SRP followed by irrigation 
with normal saline.
• Group B (Test group): SRP followed by diode laser 
application (laser assisted new attachment procedure, 
LANAP) and irrigation with normal saline.
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Randomization
The randomization of 36 patients was done as follows. 
36 type 2 diabetes and CP reported to the investigator 
of the study. The investigator who was blind to the study 
protocol then randomly assigned 36 patients into test and 
control group by sequentially numbered sealed opaque 
envelopes. The operator then according to the treatment 
assigned in the sealed envelope treated the patients either 
by SRP alone or SRP+LANAP and then recalled the 
patients after 3 months for follow-up.
All the patients who had participated in the study fulfilling 
the inclusion criteria had to fill an informed consent prior 
to the study.
Study Protocol
• In the first visit oral hygiene instructions were given.
• Patients were then recalled after 7 days for baseline 
blood investigation (HbA1c), a collection of 
subgingival plaque samples and measurements 
of clinical parameters followed by nonsurgical 
periodontal therapy in control group and SRP 
followed by LANAP in the test group.
• Subgingival plaque samples were sent for 
microbiological analysis.
• Laser application was done with the help of an active 
diode laser (Mikro® Sunny 808 nm diode laser). A 
wavelength 808 nm and a power setting of 1.5 W-1.8 
W were used in continuous, contact mode with a thin 
flexible fiber-optic cable (320 nm). The fiber optic 
cable was introduced into the periodontal pocket 
with the laser beam directed towards the soft tissue 
of the pocket wall and moved in an apico-coronal 
direction, with a sweeping motion. The depth of the 
periodontal pocket in millimeters corresponds to the 
exposure time in seconds
• Patients were again recalled at 3 months for 
assessment of clinical, microbiological and HbA1c 
level posttreatment.
• Patients were monitored periodically for oral hygiene 
maintenance and recalled for further periodontal 
therapy as needed.
Clinical Parameters Assessed
Baseline and 3 months assessment of the following full 
mouth clinical parameters:
• Plaque index (PI) (Silness and Loe,1964)24
• Gingival index (GI) (Loe and Silness,1967)24
• CAL - using a UNC-15 probe from a fixed reference 
point on the crown to the base of the pocket.
• Probing depth (PD) - using a UNC-15 probe taken 
from the margin of the gingiva to the base of the 
pocket.
Microbiological Analysis
The collection of plaque sample was done in the 
Department of Periodontology, JSS Dental College, 
and Hospital, Mysuru. Collection of subgingival plaque 
samples was done by the same operator to standardize 
the sampling procedure. Before sampling, the adjacent 
teeth were isolated with cotton rolls. To standardize site 
selection and adequate sample volume, plaque sample was 
collected from all the quadrants and pooled in reduced 
transport fluid (RTF) medium for microbiological 
analysis. Plaque samples contaminated with blood and 
saliva were discarded. The samples were then immediately 
transferred for microbiological culturing of Aa and Pg 
which were then separately vortexed and inoculated in 
anaerobic jar according to the requirement for culturing 
A total of 40 DM2 patients with CP were selected from the Department of Periodontology, JSS 





• Patients between 30-60 years of age with confirmed diagnosis of DM2 and chronic 
generalized periodontitis with ≥20 teeth remaining. 
• The periodontal pocket depth of 4-7 mm with clinical attachment level (CAL) of 2 mm or 
greater and each quadrant having at least 3 teeth. 
• Consenting patients who were cooperative and able to come for regular follow up. 
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Fig 1: Consort diagram of the study 
 
 
Assessed for eligibility (n=78) 
Non-insulin dependent diabetes mellitus patients with Chronic periodontitis (n=40) 
Randomization (n=40) 
Group A (Control) 
SRP (n=20) 
Lost during follow up (n=2) 
Group B (Test) 
SRP+LANAP (n=20) 
Lost during follow up (n=2) 
Figure 1. Consort Diagram of the Study.
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and quantification of anaerobic bacteria.
Statistical Analysis
The values obtained from the clinical, microbiological 
and hematological data were subjected to following 
statistical analysis:
• Descriptive statistics – mean and standard deviation. 
• Paired samples “t-test” for within group comparison.
• Independent-samples t test for comparison between 
2 groups.
The data obtained were processed using statistical 
software (SPSS 22 for Windows).
Results
The study outline is explained in Figure 1. The 
demographic data of the patients at baseline are illustrated 
in Table 1.
Clinical Parameters 
There was a statistically significant improvement 
Table 1. Demographic Data of the Test (SRP+LANAP) and Control (SRP) 
Group at Baseline
SRP (n = 18) SRP+LANAP (n = 18)





HbA1c mean (%) 7.994±1.2744 8.122±1.2744
PI 2.3194±0.26352 2.45±0.25
GI 2.38667±0.369610 2.19±0.2234
PD (mm) 3.5911±0.33582 3.6406±0.3902
CAL (mm) 8.7361±0.7682 8.6739±0.7046
Abbreviations: PI, plaque index; GI: gingival index: PD: probing depth; 
CAL: clinical attachment level; SRP: scaling and root planning; LANAP: 
Laser-assisted new attachment procedure.
Table 2. Clinical Parameters Assessment at Day Zero and 90 Days in the Test and Control Groupsa
Clinical Parameter Evaluation Point Group A (SRP) Group B (SRP+LANAP) P Value 
PI
Day 0 2.3194±0.26352 2.45±0.25
0.003b90 days 1.56917±0.323484 1.26±0.22
P value 0.000b 0.000b
GI
Day 0 2.38667±0.369610 2.19±0.2234
0.000b90 days 1.5556±0.32333 1.04±0.2275
P value 0.000b 0.000b
PD (mm)
Day 0 3.5911±0.33582 3.6406±0.3902
0.000b90 days 2.6339±0.39313 1.8050±0.3278
P value 0.000b 0.000b
CAL(mm)
Day 0 8.7361±0.7682 8.6739±0.7046
0.000b90 days 7.5011±0.5242 6.6511±0.5315
P value 0.000b 0.000b
Abbreviations: PI, plaque index; GI, gingival index; PD, probing depth; CAL, clinical attachment level; SRP, scaling and root planning; 
LANAP, Laser-assisted new attachment procedure. 
a Data are shown as Mean ± SD.
b Statistically significant.
in clinical parameters from baseline to 3 months 
postoperatively (P < 0.001) (Table 2). The results are 
displayed in boxplots diagrams in Figure 2. 
HbA1c(%)
The results of HbA1c values are depicted in Figure 
3. The values of HbA1c in the test site decreased from 
8.122± 1.26 at baseline to 6.833 ± 0.651 at 3 months 
and in the control, site decreased from 7.994 ± 1.27 at 
baseline to 7.217± 0.793 at 3 months. There was 6.49% 
more reduction in HbA1c levels in the SRP+LANAP 
group compared to SRP alone (16.25% vs. 9.76%) but 
on intergroup comparison the difference in HbA1c 
reduction was nonsignificant. The changes in HbA1c(%) 
are shown in Table 3.
Microbiological Analysis
The collection of subgingival plaque samples for the 
culturing of anaerobic bacteria was done at baseline and 
3 months postoperatively. The results in CFU/mL of Aa 
and Pg are shown in (Figure 4).
Colony Count of Aa (CFU/mL)
The colony count of Aa in control group decreased from 
104.44 ± 20.643 to 56.11 ± 19.363 and from 112.78 ± 
19.33 to 15.00 ± 8.22 in the test group. The comparison 
between the treatment groups revealed 46.27% reduction 
of Aa in control group and 86.69% reduction of Aa in 
test showing that test group had 40.4% more significant 
reduction in Aa than control. Thus, on intergroup 
comparison statistical significant reduction was observed 
in colony count of Aa in test group than in control after 3 
months (Table 4, Figure 4)
Colony Count of Pg (CFU/mL)
The colony count of Pg in CFU/ml decreased from 102.50 
± 33.61 at the baseline to 14.72 ± 12.18 at 3 months in the 
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test group and from 101.39 ± 33.64 at the baseline to 50.00 
± 21.351 at three months in control. The comparison 
between the treatment groups revealed 85.15% reduction 
of Pg in test group and 50.64% reduction of Pg in 
control group showing that the test group had 35% more 
significant reduction of Pg than in control.
Thus, on intergroup comparison statistical significant 
reduction was observed in colony count of Pg in test 
group than in control after 3 months (Table 4, Figure 4).
Discussion
The current study shows a better reduction of HbA1c 
levels, in laser treated group (16.25%) than in SRP treated 
group (9.76%) after 3 months but this reduction was not 
statistically significant on the intergroup comparison from 
baseline to 3 months. The values of HbA1c at 3 months 
Figure 2. A) Plaque Index B) Gingival Index C) Probing Depth D) Clinical Attachment Level Assessed at Day Zero and 90 Days Posttreatment.
decreased from 7.994± 1.27 at baseline to 7.217± 0.793 at 3 months. There was 6.49% more 
reduction in HbA1c levels in the SRP+LANAP group compared to SRP alone (16.25% vs. 
9.76%) but on intergroup comparison the difference in HbA1c reduction was nonsignificant. The 
changes in HbA1c(%) are shown in Table 3, Figure 3. 
 






Group A SRP Group B 
SRP+LANAP 
P value  
HbA1c(%) Day 0 7.994±1.2744 8.122±1.2744 .121 
90 days 7.2178±0.79353 6.8333±.65169 
Sig. value 0.000* 0.000* 
Abbreviations: HbA1c: Glycated hemoglobin level 
 
Fig. No. 3: Boxplots shows Mean HbA1c(%) level at day 0 and 90 days in SRP group 




The collection of subgingival plaque samples for the culturing of anaerobic bacteria was done at 
baseline and 3 months postoperatively. The results in CFU/ml of Aa and Pg are shown in (Fig. 4). 
 
Colony count of Aa (CFU/ml) 
The colony count of Aa in control group decreased from 104.44± 20.643 to 56.11± 19.363 and 
from 112.78± 19.33 to 15.00± 8.22 in the test group. The comparison between the treatment 
groups revealed 46.27% reduction of Aa in control group and 86.69% reduction of Aa in test 
showing that test group had 40.4% more significant reduction in Aa than control. Thus, on 
intergroup comparison statistical significant reduction was observed in colony count of Aa in test 
group than in control after 3 months (Table 4, Fig 4) 
 
 
Figure 3. Mean HbA1c(%) Level at Day 0 and 90 Days in SRP 
Group and SRP+LANAP Group.
Figure 4. Mean Reduction in CFU/mL of Aggregatibacter 
actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg) 
From Baseline to 3 Months.
postoperatively decreased from 8.12% to 6.8% in the test 
group (SRP+LANAP) and 7.9% to 7.2% in control group 
(SRP). In the present study, the lowering of HbA1c levels 
after nonsurgical periodontal therapy was in accordance 
with previously reported studies. 25-29
Previous studies had linked obesity and smoking as 
Colony count of Pg (CFU/mL) 
The colony count of Pg in CFU/ml decreased from 102.50± 33.61 at the baseline to 14.72± 12.18 
at 3 months in the test group and from 101.39± 33.64 at the baseline to 50.00± 21.351 at three 
months in control. The comparison between the treatment groups revealed 85.15% reduction of 
Pg in test group and 50.64% reduction of Pg in control group showing that the test group had 
35% more significant reduction of Pg than in control. 
Thus, on intergroup comparison statistical significant reduction was observed in colony count of 





Table 4: Values of Mean ± SD of Microbiological parameters in CFU/ml at day zero and 90 






Group A SRP Group B 
SRP+LANAP 
P value  
Aa( CFU/ml) Day 0 104.44±20.643 112.78±19.34 .000* 
90 days 56.11±19.369 15.00±8.225 
Sig. value 0.000* 0.000* 
Pg( CFU/ml) Day 0 101.39±33.642 102.50±33.618 .000* 
90 days 50.00±21.35 14.72±12.18 
Sig. value 0.000* 0.000* 





Fig No. 4: Boxplots shows mean reduction in CFU/ml of Aggregatibacter 
ctinomycetemcomitans(Aa) and Porphyromo as gingivalis(Pg) from baseline to 3 
months: A)Aa   B) Pg  
Colony count of Pg (CFU/mL) 
The colony count of Pg in CFU/ml decreased from 102.50± 33.61 at the baseline to 14.72± 12.18 
at 3 months in the test group and from 101.39± 33.64 at the baseline to 50.00± 21.351 at three 
months in control. The comparison between the treatment groups revealed 85.15% reduction of 
Pg in test group and 50.64% reduction of Pg in control group showing that the test group had 
35% more significant reduction of Pg than in control. 
Thus, on intergroup comparison statistical significant reduction was observed in colony count of 
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Group A SRP Group B 
SRP+LANAP 
P value  
Aa( CFU/ml) Day 0 104.44±20.643 112.78±19.34 .000* 
90 days 56.11±19.369 15.00±8.225 
Sig. value 0.000* 0.000* 
Pg( CFU/ml) Day 0 101.39±33.642 102.50±33.618 .000* 
90 days 50.00±21.35 14.72±12.18 
Sig. value 0.000* 0.000* 





Fig No. 4: Boxplots shows mean reduction in CFU/ml of Aggregatibacter 
actinomycetemcomitans(Aa) and Porphyromonas gingivalis(Pg) from baseline to 3 
months: A)Aa    B) Pg  
(A)
(B)
PI 2.3194±.26352 2.45±0.25 
GI 2.38667±.369610 2.19±.2234 
PD (mm) 3.5911±.33582 3.6406±.3902 
CAL (mm) 8.7361±0.7682 8.6739±.7046 







The study outline is explained in Figure 1. The demographic data of the patients at baseline are 
illustrated in Table 1. 
 
 
Clinical Parameters  
There was a statistically significant improvement in clinical parameters from baseline to 3 months 
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The study outline is explained in Figure 1. The demographic data of the patients at baseline are 
illustrated in Table 1. 
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Boxplots A) Plaque Index B) Gingival Index C) Probing depth D) Clinical attachment level assessed 
at zero-day and 90 days posttreatment. 
 
 
Table 2: Clinical Parameters Assessment at Zer  and 90 Days in Test and ontrol groups (Mean 





Group A SRP Group B 
SRP+LANAP 
P Value  
PI Day 0 2.3194±.26352 2.45±0.25 .003* 
90 days 1.56917±.323484 1.26±0.22 
Sig. value 0.000* 0.000* 
GI Day 0 2.38667±.3696 0 2.19±.2234 .000* 
90 days 1.5556±.32333 1.04±.2275 
Sig. value 0.000* 0.000* 
PD (mm) Day 0 3.5911±.33582 3.6406±.3902 .000* 
90 days 2.6339±.39313 1.8050±.3278 
Sig. value 0.000* 0.000* 
CAL(mm) Day 0 8.7361±0.7682 8.6739±.7046 .000* 
90 days 7.5011±0.5242 6.6511±.5315 
Sig. value 0.000* 0.000* 
Abbreviations: PI, plaque index; GI: gingival index: PD: probing depth; CAL: clinical 
attachment level; SRP: scaling and root planning; LANAP: Laser-assisted new attachment 
procedure; (*) statistically significant 
 
HbA1c(%) 
The results of HbA1c values are depicted in Figure 4. The values of HbA1c in the test site 




Boxplots A) Plaque Index B) Gingival Index C) Probing depth D) Clinical attachment level assessed 
at zero-day and 90 days posttreatment. 
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Group A SRP Group B 
SRP+LANAP 
P Value  
PI Day 0 2.3194±.26352 2.45±0.25 .003* 
90 day  1.56917±.323484 1.26±0.22 
Sig. value 0.000* 0.000* 
GI Day 0 2.38667±.369610 2.19±.2234 .000* 
90 days 1.5556±.32333 1.04±.2275 
Sig. value 0.000* 0.000* 
PD (mm) Day 0 3.5911±.33582 3.6406±.3902 .000* 
90 days 2.6339±.39313 1.8050±.3278 
Sig. value 0.000* 0.000* 
CAL(mm) Day 0 8.7361±0.7682 8.6739±.7046 .000* 
90 days 7.5011±0.5242 6.6511±.5315 
Sig. value 0.000* 0.000* 
Abbreviations: PI, plaque index; GI: gingival index: PD: probing depth; CAL: clinical 
attachment level; SRP: scaling and root planning; LANAP: Laser-assisted new attachment 
procedure; (*) statistically significant 
 
HbA1c(%) 
The results of HbA1c values are depicted in Figure 4. The values of HbA1c in the test site 




Journal of Lasers in Medical Sciences  Volume 10, Number 1, Winter 2019 61
                                                                                 Diode Laser - A Novel Therapeutic Approach
confounding factors to diabetes mellitus and HbA1c 
control in patients with CP.27 In the present study patients 
had confirmed diagnosis of DM2, with a mean BMI <24 
kg/m2, and were nonsmokers, which positively helped in 
assessing the bidirectional relationship of DM2 and CP. 
The outcome of the current study was similar with those of 
two recent investigations that examined the effect of PDT 
alone and in combination with SRP in patients receiving 
initial and supportive periodontal therapy. Because PDT 
had no reported systemic effect, there was no reason to 
assume that it would improve HbA1c levels.30,31
This is in contradiction to a recent study by Koçak and 
Sağlam which showed SRP+ Diode laser group showed 
statistically significant improvement in glycemic control 
(HbA1c) than in SRP group in patients with DM2 and 
CP.32
The present study showed improvement in all clinical 
parameters (PI, GI, PD, CAL) from baseline to 3 months 
in SRP and SRP+LANAP group which was statistically 
significant.
The value of plaque index reduced from 2.31 at baseline 
to 1.56 at 3 months in control and from 2.45 to 1.26 in the 
test group. This observation is in accordance with a study 
done by Berakdar et al. 33 
The value of GI score reduced from 2.23 at baseline to 
1.55 at 3 months after therapy in control and from 2.19 to 
1.04 in the test group. This is in accordance with a study 
by Fallah where after 6 weeks there is compelling evidence 
of improvement in gingival.34
The mean reduction of PD and CAL from baseline to 
3 months in the present study were similar with those 
obtained by other studies.7,35-38 A study was done by 
Obradovic et al where laser as an adjunct to SRP showed 
significant improvement in gingival inflammation 
compared to SRP alone in NIDDM patients.39 Another 
histologic study by Obradovic et al, showed a faster 
healing response when SRP was combined with DL in 
NIDDM patients.40
In a study by Yukna et al laser as an adjunct to SRP 
resulted in significant reduction of PD with a gain in 
CAL.41 This reduction in PD can be explained due to 
better pocket epithelial lining removal by soft tissue diode 
laser leading to connective tissue attachment directly to 
root surface favoring regeneration as reported by Kreisler 
et al.36 A similar study conducted on animals by Romanos 
et al.42 showed better removal of pocket epithelial 
lining in DL+SRP group compared to conventional 
hand instruments. Hence, the abovementioned studies 
suggest that a better response in clinical parameters can 
be achieved when diode laser is used as an adjunct to 
conventional SRP.
The present study showed a significant reduction in 
colony count (CFU/mL) of Aa and Pg from base line to 
3 months follow-up in both the groups. The colony count 
of Aa in control group decreased from 104.44 ± 20.643 to 
56.11 ± 19.363 and from 112.78 ± 19.33 to 15.00 ± 8.22 in 
the test group. The microbial count of Aa revealed 46.27% 
reduction in control group and 86.69% reduction in test 
showing that test group had 40.4% more reduction in 
Aa than control. Also, the colony count of Pg (CFU/mL) 
decreased from 102.50 ± 33.618 at the baseline to 14.72 
± 12.184 at 3 months in the test group and from 101.39 
± 33.642 at the baseline to 50.00 ± 21.351 at 3 months in 
control. The mean percentage decrease of Pg was 50.64% 
in control group and 85.15% in test group showing that the 
test group had 35% more reduction of Pg than in control. 
This is because of the fact that diode laser is effective 
against many putative periodontal pathogens including 
Table 3. Glycemic Parameters in Group A and Group Ba
Clinical Parameter Evaluation Point Group A (SRP) Group B (SRP+LANAP) P Value 
HbA1c (%)
Day 0 7.994±1.2744 8.122±1.2744
0.12190 days 7.2178±0.79353 6.8333±.65169
P value 0.000b 0.000b
Abbreviation: HbA1c: Glycated hemoglobin level. 
a Data are shown as Mean ± SD.
b Statistically significant.
Table 4. Microbiological Parameters in CFU/mL at Day Zero and 90 Days in the Test and Control Groupsa
Clinical Parameter Evaluation Point Group A (SRP) Group B (SRP+LANAP) P Value 
Aa (CFU/mL)
Day 0 104.44±20.643 112.78±19.34
0.000b90 days 56.11±19.369 15.00±8.225
P value 0.000b 0.000b
Pg (CFU/mL)
Day 0 101.39±33.642 102.50±33.618
0.000b90 days 50.00±21.35 14.72±12.18
P value 0.000b 0.000b
Abbreviations: Aa, Aggregatibacter actinomycetemcomitans; Pg, Porphyromonas gingivalis. 
a Data are shown as Mean ± SD.
b Statistically significant.
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Aa and Pg and its ability to reach inaccessible periodontal 
sites which had been proved in previous studies.43
Thus, the present study shows that diode laser 
application is effective in reducing inflammation due 
to the antimicrobial property of laser. A classic study 
by Pick and Colvard et al in 1998 on the treatment of 
periodontal pockets using 810 nm diode lasers showed 
immediate structural damage of gram-negative bacteria 
and a marked reduction of periodontopathogens namely 
Aa and Pa.7,44 Diode laser is effective not only in the 
elimination of bacteria from the periodontal pocket but 
also the complete removal of bacterial toxins from root 
cementum.45 Another study by Lin et al showed marked 
reduction of Aa and prevent further recolonization for up 
to 28 days using diode lasers.46
Conclusion
The present study showed statistically significant 
improvement in clinical and microbiological parameters 
in the test than in control group from baseline to 3 months. 
Thus we can conclude that the use of diode laser therapy 
after SRP is more effective than SRP alone in the overall 
improvement of clinical and microbiological parameters. 
Also, the adjunctive use of soft tissue diode laser resulted 
in better improvement in HbA1c in NIDDM patients 
than SRP alone after 3 months. The percentage decrease 
in HbA1c was (16.25%) in test versus (9.76 %) in control 
but the difference between the groups was not statistically 
significant. This suggests the need for further long-term 
randomized controlled clinical trials with larger sample 
size before generalizing that diode laser therapy results 
in improved glycemic control in maturity onset diabetes 
mellitus patients with CP.
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